SPIA
DNTH icon

Steward Partners Investment Advisory’s Dianthus Therapeutics DNTH Stock Holding History

Steward Partners Investment Advisory’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,141
Closed -$86K – 4004
2024
Q3 		$86K Buy
+3,141
New +$87.5K ﹤0.01% 1955
2019
Q3 		– Sell
-3
Closed – – 2644
2019
Q2 		$0 Buy
+3
New +$742 ﹤0.01% 2621

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Steward Partners Investment Advisory's DNTH Position: Q4 2024 in Review

Steward Partners Investment Advisory sold out of Dianthus Therapeutics (DNTH) in Q4 2024, closing a stake of 3,141 shares — an estimated $86K sold.

Steward Partners Investment Advisory first reported a position in DNTH in Q2 2019 and held it in 2 quarters. The position peaked at $86K in Q3 2024. 95 funds tracked by Wall St. Rank hold DNTH as of Q4 2024.

  • Steward Partners Investment Advisory reported no remaining Dianthus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 3,141 Dianthus Therapeutics shares in Q4 2024, an estimated $86K.
  • Steward Partners Investment Advisory first reported a position in Dianthus Therapeutics in Q2 2019 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Dianthus Therapeutics position peaked at $86K in Q3 2024.
  • 95 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q4 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2024, filed 6 Feb 2025.